Request Sample

Global Infectious Disease Diagnostics Market

March 16, 2018

Global Infectious Disease Diagnostics Market, By Product Type (Assays, Kits & Reagents, and Instruments ), By Technology (Microscopy, Immunodiagnostics, Nucleic acid amplification test, Polymerase Chain Reaction, Immunofluorescence Antibody Test (IFAT), and Others), By Application (HIV, Pneumonia, Hepatitis, Tuberculosis (TB), Influenza (Flu), Methicillin-resistant Staphylococcus Aureus (MRSA), and Other Emerging Infections), By End-User (Hospital, Diagnostics and Clinical Laboratories, Academic and Research Institutes, and Others) By Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) - Global Forecast, 2020-2025.

Report Code :FMR350      
Pages :291 Pages
Format :   PPT Format   PDF Format

The global infectious disease diagnostics market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). Most of the infectious diseases are caused by pathogens including viruses, bacteria, and fungi. There are different types of laboratory test available to detect the main cause of the infections. In microbiology field, infectious disease diagnostics plays an important role, as it detects and identifies the nature of the disease, which enables the patient to receive proper treatment to control or prevent the infection. Moreover, infectious disease diagnostic tests such as rapid diagnostic test (RDT) and point-of-care (POC) diagnostic test are used in detection of infectious diseases such as malaria, dengue, emerging infections such as infection caused by Ebola, chikungunya, Zika, and other viruses, and typhoid. Major players such as Thermo Fischer Scientific, Bio Mérieux SA, Roche Diagnostics, Abbott Laboratories, and others, offer wide range of diagnostics tests to detect such infections.

Table 1. Global INFECTIOUS DISEASE DIAGNOSTICS MARKET SYNOPSIS

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (By Product Type)

Assays, Kits & Reagents, and Instruments

Market Segmentation (By Technology)

Microscopy, Immunodiagnostics, Nucleic acid amplification test, Polymerase Chain Reaction, Immunofluorescence Antibody Test (IFAT), and Others

Market Segmentation (By Application)

HIV, Pneumonia, Hepatitis, Tuberculosis (TB), Influenza (Flu), Methicillin-resistant Staphylococcus Aureus (MRSA), and Other Emerging Infections

Market Segmentation (By End-User)

Hospital, Diagnostics and Clinical Laboratories, Academic and Research Institutes, and Others

Regions Covered

North America, Latin America, Europe, Asia-Pacific, Middle East and Africa

Key Players Coverage

Biomérieux SA, Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Danaher Corporation, DiaSorin S.p.A, Roche Diagnostics, Quidel Corporation, Thermo Fisher Scientific, Cepheid, Inc., Hologic, Inc., Chembio Diagnostic Systems, Inc. among others

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

Market Dynamics

The infectious disease diagnostics market is expected to show significant growth owing to the increasing incidence of the various infectious diseases such as malaria, influenza, and other viral infectious diseases, globally. For instance, recently in the first quarter of 2020 (April 06, 2020), the coronavirus infection has affected around 1,318,306 people globally. This coronavirus pandemic has increased the demand for assays, test kits, and other diagnostics in most of the countries.

Moreover, for detection of this novel coronavirus, manufacturers launched innovative test kits. On 24th March 2020, Mylab, received the Indian FDA / Central Drugs Standard Control Organization (CDSCO) approval for its reverse transcription polymerase chain reaction (RT-PCR) tests. The test can study 1,000 samples from large laboratories and 200 samples from small laboratories. Thus, factors such as infectious disease outbreak, and the development of novel infectious diagnostics testing kits are contributing to growth of the global infectious disease diagnostics market.

However, mechanical and technological defects associated with diagnostics kit is expected to hamper the market growth. These defects may lead to product recall, which affects the company’s manufacturing capabilities and efficiency. For instance, in August 2018, the U.S. FDA issued the product recall notice for Gram Positive AST Cards (VITEK 2 Gram Positive Cefoxitin Screen and VITEK 2 Gram Positive AST for Oxacillin), manufactured by BioMerieux S.A., due to false Methicillin-resistant Staphylococcus aureus (MRSA) results.

Figure 1. PORTER’S Analysis

 

Note: The above figure shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

North America is expected to hold a dominant position in the global infectious disease diagnostics market, attributed to the increasing prevalence of the infectious disease in the region. According to Centers for Disease Control and Prevention estimation for influenza season 2019-2020, there were around 39 million flu illnesses, 400,000 hospitalizations and 24,000 deaths occurred from flu, in the U.S. Moreover, other emerging infections such as coronavirus is highly prevalent in the U.S. These increasing incidences lead to increasing demand for the diagnostic kits, assay, and so on, thereby driving the growth of the North America infectious disease diagnostics market.

Moreover, Europe infectious disease diagnostics market is expected to show significant market growth owing to the availability of CE marked products for diagnosis of infectious diseases in the region. For instance, in April 2017, BioGx, a molecular diagnostic products manufacturer, received the CE-IVD marking for four real-time PCR-based tests for infectious disease. Moreover, in August 2016, BioLytical Laboratories Inc., received the CE marking for its INSTI HIV Self-Test. The test is available in the UK, France and other key European countries.

Figure 2. Regional Analysis

 

Note: The above figure shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

Competitive Landscape

Key players in the global infectious disease diagnostics market include: Biomérieux SA, Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Danaher Corporation, DiaSorin S.p.A, Roche Diagnostics, Quidel Corporation, Thermo Fisher Scientific, Cepheid, Inc, Quest Diagnostics, Inc., Hologic, Inc., Chembio Diagnostic Systems, Inc. among others.

Adoption of the inorganic growth strategies such as collaboration, acquisition, and merger by the key players is expected to drive the global infectious disease diagnostics market. For instance, in August 2018, Bruker Corporation has acquired the Hain Lifescience GmbH, an infectious disease molecular diagnostics firm (MDx). This acquisition has enabled the Bruker Corporation to expand its presence in microbiology and virology infectious disease molecular diagnostics industry.

Figure 3. Market Share of Key Players, 2019

 

Note: The above figure shown for illustrative purposes only, the actual data may vary and will be incorporated in the report..

By Product Type

  • Assays, Kits & Reagents
  • Instruments

By Technology

  • Microscopy
  • Immunodiagnostics
  • Isothermal Nucleic Acid Amplification Test
  • Polymerase Chain Reaction
  • Immunofluorescence Antibody Test (IFAT)
  • Others

By Application

  • HIV
  • Pneumonia
  • Hepatitis
  • Tuberculosis (TB)
  • Influenza (Flu)
  • Methicillin-resistant Staphylococcus Aureus (MRSA)
  • Other Emerging Infections

By End-User

  • Hospitals
  • Diagnostics and Clinical Laboratories
  • Academic and Research Institutes
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides an in-depth analysis of the global infectious disease diagnostics market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by key players in the global infectious disease diagnostics market?
  • What key factors are expected to increase the demand for infectious disease diagnostics market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global infectious disease diagnostics market?  
  • What is the total market value (US$ Mn) generated in global infectious disease diagnostics market by product type in 2019 and what are the forecasts by 2025?
  • Which technology (microscopy, immunodiagnostics, nucleic acid amplification test, polymerase chain reaction, immunofluorescence antibody test (IFAT), and others) is expected to dominate the global infectious disease diagnostics market in the coming years?
  • Which application and end user are expected to propel the global infectious disease diagnostics market in the foreseen future?
  • What was the total revenue generated by the global infectious disease diagnostics market across different regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • Who are the key players contributing to the growth of the global infectious disease diagnostics market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the global infectious disease diagnostics market?
  • What are the major outcomes derived from the Porter’s five forces?
  • What new products are going to be approved or launched in the coming years which may have huge impact in the market?
  • What insights are derived through the analysis of key players on following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?

Latest Reports

Global Sleep Testing Services Market

Global Sleep Testing Services Market, By Test Type (Home Sleep Testing and In-lab Sleep Testing (Electroencephalogram, Full Polysomnography, CPAP/BiPAP …

Read More

Global Sarcoma Biopsy Market

Global Sarcoma Biopsy Market, By Product Type (Reusable Device, Disposable Devices), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic …

Read More

Global Rheumatoid Arthritis Diagnostic Tests Market

Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (serology tests (erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic …

Read More

Global PARP Inhibitor Biomarkers Market

Global PARP Inhibitor Biomarkers Market, By Product and Service Type (Product Type, (Kits, Assays), Service Type, (BRCA 1 & …

Read More

North America Outbound Medical Tourism Services Market

North America Outbound Medical Tourism Services Market, By Treatment Type (Cardiovascular Treatment, Cosmetic Surgery Treatment, Dental Treatment, Weight Loss …

Read More

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product Type (Instruments and Reagents and Kits ), By …

Read More

Global Bilirubin Blood Test Market

Global Bilirubin Blood Test Market, By Test Type (Direct/Conjugated Bilirubin Test, Indirect/Unconjugated Bilirubin Test, Total Serum Bilirubin (TSB), By …

Read More

Global In Vitro Toxicity Testing Market

Global In Vitro Toxicity Testing Market, By Product & Service (Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based …

Read More
Validation error occured. Please enter the fields and submit it again.